Streetbeat News

Price Targets

AES

UBS analyst Daniel Ford has downgraded AES (NYSE:AES) from Buy to Neutral and lowered the price target from $22 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 9:22 am

UVSP

Keefe, Bruyette & Woods analyst Michael Perito has downgraded Univest Financial (NASDAQ:UVSP) from Outperform to Market Perform and lowered the price target from $24 to $20.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 9:15 am

PTCT

Truist Securities analyst Robyn Karnauskas has downgraded PTC Therapeutics (NASDAQ:PTCT) from Buy to Hold and set a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 9:10 am

ELF

Jefferies analyst Ashley Helgans has upgraded e.l.f. Beauty (NYSE:ELF) from Hold to Buy and announced a price target of $115.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:54 am

YETI

Keybanc analyst Noah Zatzkin maintains an Underweight rating on YETI Holdings and lowers the price target from $34 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:25 am

MTRN

Keybanc analyst Philip Gibbs maintains an Overweight rating on Materion (NYSE:MTRN) but lowers the price target from $133 to $128.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:21 am

ANGO

Raymond James analyst Jayson Bedford has maintained an Outperform rating on AngioDynamics (NASDAQ:ANGO) but lowered the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:16 am

APLS

Raymond James analyst Steven Seedhouse has maintained a 'Strong Buy' rating on Apellis Pharmaceuticals (NASDAQ:APLS) and raised the price target from $89 to $92.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:13 am

GLOB

Piper Sandler analyst Arvind Ramnani maintains an Overweight rating on Globant (NYSE:GLOB) and raises the price target from $209 to $230.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:09 am

CIVI

In the last quarter, Civitas Resources (NYSE:CIVI) received 2 bullish, 2 somewhat bullish, and 3 indifferent analyst ratings. Over the past 3 months, 7 analysts have offered 12-month price targets for the company, with an average price target of $94.29, a high of $102.00, and a low of $87.00. The average price target has increased by 5.23% over the past month.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 8:00 pm